Case 1:07-md-01866-GMS
Document 85
Filed 09/03/2008
Page 1 of 5
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE IN RE: BRIMONIDINE PATENT LITIGATION C.A. No. 07-md-1866-GMS
MOTION TO STAY CASE AGAINST EXELA, TOLL THE 30-MONTH HATCH-WAXMAN ACT STAY, AND ALLOW ALLERGAN TO USE INFORMATION PRODUCED IN THIS CASE TO PREPARE A CITIZENS' PETITION TO BE FILED WITH THE FDA Plaintiff Allergan, Inc. respectfully moves this Court to enter an Order staying the abovecaptioned action against Exela PharmSci, Inc., Exela PharmSci Pvt., Ltd., Paddock Laboratories, Inc., and PharmaForce, Inc., tolling the 30-month stay under the Hatch-Waxman Act until the Court lifts the stay in this case, and granting leave of the Court to use information produced under the protective order in this case in a citizen's petition that Allergan will file with the FDA. The reasons supporting this motion are set forth in Allergan's opening brief filed herewith.
Case 1:07-md-01866-GMS
Document 85
Filed 09/03/2008
Page 2 of 5
Dated: September 3, 2008
FISH & RICHARDSON P.C.
By: /s/ William J. Marsden, Jr. William J. Marsden, Jr. (#2247) Susan M. Coletti (#4690) 919 N. Market Street, Suite 1100 P.O. Box 1114 Wilmington, DE 19899-1114 Telephone: (302) 652-5070 Email: [email protected] [email protected] Jonathan E. Singer Michael J. Kane Deanna J. Reichel FISH & RICHARDSON P.C. 60 South Sixth Street, Suite 3300 Minneapolis, MN 55402 Telephone: (612) 335-5070 Juanita Brooks FISH & RICHARDSON P.C. 12390 El Camino Real San Diego, CA 92130 Telephone: (858) 678-5070 W. Chad Shear FISH & RICHARDSON P.C. 1717 Main Street, Suite 5000 Dallas, TX 75201 Telephone: (214) 747-5070 ATTORNEYS FOR ALLERGAN, INC.
Case 1:07-md-01866-GMS
Document 85
Filed 09/03/2008
Page 3 of 5
CERTIFICATION PURSUANT TO DISTRICT OF DELAWARE LOCAL RULE 7.1.1 Counsel for Plaintiff Allergan, Inc. has consulted with counsel for Exela PharmSci, Inc., Exela PharmSci Pvt., Ltd., Paddock Laboratories, Inc., and PharmaForce, Inc., pursuant to District of Delaware Local Rule 7.1.1 and have been advised that they will not consent to the relief sought by the Motion.
/s/ William M. Marsden, Jr. William J. Marsden, Jr. (#22247)
Case 1:07-md-01866-GMS
Document 85
Filed 09/03/2008
Page 4 of 5
Dated: September 3, 2008
FISH & RICHARDSON P.C.
By: /s/ William J. Marsden, Jr. William J. Marsden, Jr. (#2247) Susan M. Coletti (#4690) 919 N. Market Street, Suite 1100 P.O. Box 1114 Wilmington, DE 19899-1114 Telephone: (302) 652-5070 Email: [email protected] Jonathan E. Singer Michael J. Kane Deanna J. Reichel FISH & RICHARDSON P.C. 60 South Sixth Street, Suite 3300 Minneapolis, MN 55402 Telephone: (612) 335-5070 Juanita Brooks FISH & RICHARDSON P.C. 12390 El Camino Real San Diego, CA 92130 Telephone: (858) 678-5070 W. Chad Shear FISH & RICHARDSON P.C. 1717 Main Street, Suite 5000 Dallas, TX 75201 Telephone: (214) 747-5070 Attorneys for Allergan, Inc.
Case 1:07-md-01866-GMS
Document 85
Filed 09/03/2008
Page 5 of 5
CERTIFICATE OF SERVICE I hereby certify that on September 3, 2008, I hereby served MOTION TO STAY CASE AGAINST EXELA, TOLL THE 30-MONTH HATCH-WAXMAN ACT STAY, AND ALLOW ALLERGAN TO USE INFORMATION PRODUCED IN THIS CASE TO PREPARE A CITIZENS' PETITION TO BE FILED WITH THE FDA on the following counsel of record at the address and in the manner indicated below: BY FEDERAL EXPRESS Daniel G. Brown Barry S. White Arthur L. Hoag Frommer Lawrence & Haug LLP 745 Fifth Avenue New York, NY 10151 BY FEDERAL EXPRESS Krista Leigh Lynch Erin M. Dunston Sharon E. Crane Bingham McCutchen LLP 2020 K Sreet NW Washington, DC 20006-1806 BY HAND DELIVERY Frederick L. Cottrell III Kelly E. Farnan Richards Layton & Finger, P.A. One Rodney Square 920 N. King Street P.O. Box 551 Wilmington, DE 19899
A redacted copy of this filing prepared pursuant to L.R. 5.1.3 and CM/ECF XIV.C will be served upon counsel for Apotex. Counsel for Apotex is not being served with this unredacted filing because it contains confidential information of Exela. Pursuant to an agreement of the parties, confidential information received from one defendant, in this instance Exela, may not be disclosed to the other defendant, in this instance Apotex. /s/ William J. Marsden, Jr. William J. Marsden, Jr.
2008-09-03 Brimondine Final Motion.doc
Case 1:07-md-01866-GMS
Document 85-2
Filed 09/03/2008
Page 1 of 1
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE IN RE: BRIMONIDINE PATENT LITIGATION
C.A. No. 07-md-1866-GMS
PROPOSED ORDER GRANTING MOTION TO STAY CASE AGAINST EXELA, TOLL THE 30-MONTH HATCH-WAXMAN ACT STAY, AND ALLOW ALLERGAN TO USE INFORMATION PRODUCED IN THIS CASE TO PREPARE A CITIZENS' PETITION TO BE FILED WITH THE FDA IT IS HEREBY ORDERED that: 1. Plaintiff Allergan, Inc's Motion to Stay this case is GRANTED, and the case
against Exela PharmSci, Inc., Exela PharmSci Pvt., Ltd., Paddock Laboratories, Inc., and PharmaForce, Inc. is stayed, the 30-month stay under the Hatch-Waxman Act is tolled until the Court lifts the stay in this case, and leave of the Court to use information produced under the protective order in this case in a citizen's petition that Allergan will file with the FDA is granted.
Dated: ______________, 2008
_____________________________________________ CHIEF, UNITED STATES DISTRICT COURT JUDGE
Proposed Order re Motion to Stay.doc